HWAIF.US Healwell AI Inc.
- Market cap
- USD 140M
- P/E
- -
- P/B
- 1.69x
- ROE
- -18.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HWAIF.US undervalued?
Graham numberThe Graham number of Healwell AI Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Healwell AI Inc. fundamental analysis
No fundamental analysis for Healwell AI Inc. yet.
Healwell AI Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Healwell AI Inc.
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability soft…
Full company profileHealwell AI Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Healwell AI Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 46.3M | 38.6M | 47.8M | 10.4M | 7.32M | 19.7M | 104M | 132M |
| Gross Profit | 15.3M | 64.2M | 15.0M | 3.71M | 1.26M | 10.8M | 57.3M | 72.7M |
| Operating Income | -1.29M | 50.5M | -16.4M | -17.3M | -16.8M | -30.4M | -29.5M | -24.4M |
| EBITDA | - | - | - | -13.9M | -27.8M | -15.9M | -13.3M | 13.8M |
| Net Income | -122K | -1.03M | -15.7M | -21.1M | -31.6M | -26.3M | -47.1M | -21.8M |
| EPS | 0.00 | -0.01 | -0.18 | -0.24 | -0.27 | -0.13 | -0.15 | -0.07 |
| Balance Sheet | ||||||||
| Total Assets | 22.7M | 22.4M | 60.9M | 45.6M | 53.7M | 126M | 285M | 283M |
| Total Liabilities | 20.4M | 22.1M | 31.1M | 32.1M | 32.2M | 51.9M | 161M | 165M |
| Shareholders' Equity | 2.26M | 237K | 29.7M | 13.5M | 21.5M | 73.7M | 124M | 118M |
| Cash & Short-term Investments | 1.13M | 894K | 7.14M | 1.41M | 19.2M | 9.41M | 18.6M | 14.9M |
| Cash Flow | ||||||||
| Operating Cash Flow | 3.21M | 4.22M | -7.10M | -8.35M | -6.30M | -22.6M | -19.4M | 7.86M |
| Capital Expenditure | 122K | 234K | 2.37M | 1.17M | 231K | 1.31M | 4.47M | 7.34M |
| Free Cash Flow | 3.09M | 3.99M | -9.47M | -9.51M | -6.53M | -23.9M | -23.9M | 517K |
| Ratios | ||||||||
| ROE | -5.4% | -434.2% | -52.7% | -156.3% | -147.2% | -35.7% | -38.0% | -18.5% |
| ROA | -0.5% | -4.6% | -25.7% | -46.2% | -58.8% | -20.9% | -16.5% | -7.7% |
| Net Profit Margin | -0.3% | -2.7% | -32.8% | -202.3% | -431.8% | -133.4% | -45.4% | -16.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Healwell AI Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | CAD 2.01M | 0.02 | - |
| 2019 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Healwell AI Inc.
- Insiders 49.41%
- Institutions 0.00%
- Public & others 50.60%
- Shares outstanding 304M
- Free float 176M
Healwell AI Inc. company profile
- Company name
- Healwell AI Inc.
- Ticker
- HWAIF.US
- ISIN
- CA42249X1006
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 570
- Fiscal year end
- December
- Address
- 460 College Street, Toronto, ON, Canada, M6G 1A1
- Website
- healwell.ai
About Healwell AI Inc.
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
Healwell AI Inc. management
10- Mr. James LeeChief Executive Officer
- Dr. Alexander Julian DobranowskiFounder, President, MD & Director
- Mr. Anthony LamChief Financial Officer
- Mr. Brad PorterChief Commercial Officer & Director
- Sean ChurchChief Financial Officer of Orion Health
- Mark McAllister M.D.Chief Executive Officer of Verosource Solutions
- Mr. Sacha GeraChief Operating Officer
- Nolan ReedsVice President of Marketing & Communications
- Mr. Blake CorbetSenior Vice President of Corporate Development
- Ms. Madeline D. WalkerPresident of MCI Medical · born 1947